Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.

Tuberculosis (TB) patients face substantial delays prior to treatment initiation, and out of pocket (OOP) expenditures often surpass the economic productivity of the household. We evaluated the pre-diagnostic cost and health seeking behaviour of new adult pulmonary TB patients registered at Primary...

Full description

Bibliographic Details
Main Authors: Karun Sandeep Veesa, Kamalabhai Russell John, Patrick K Moonan, Saravanakumar Puthupalayam Kaliappan, Krishna Manjunath, Karuna D Sagili, Chinnappareddy Ravichandra, Pradeep Aravindan Menon, Chandrakumar Dolla, Nancy Luke, Kaivan Munshi, Kuryan George, Shantidani Minz
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5802859?pdf=render
id doaj-70d15138b37e4a3e8191019e602e08d0
record_format Article
spelling doaj-70d15138b37e4a3e8191019e602e08d02020-11-25T00:51:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01132e019159110.1371/journal.pone.0191591Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.Karun Sandeep VeesaKamalabhai Russell JohnPatrick K MoonanSaravanakumar Puthupalayam KaliappanKrishna ManjunathKaruna D SagiliChinnappareddy RavichandraPradeep Aravindan MenonChandrakumar DollaNancy LukeKaivan MunshiKuryan GeorgeShantidani MinzTuberculosis (TB) patients face substantial delays prior to treatment initiation, and out of pocket (OOP) expenditures often surpass the economic productivity of the household. We evaluated the pre-diagnostic cost and health seeking behaviour of new adult pulmonary TB patients registered at Primary Health Centres (PHCs) in Vellore district, Tamil Nadu, India.This descriptive study, part of a randomised controlled trial conducted in three rural Tuberculosis Units from Dec 2012 to Dec 2015, collected data on number of health facilities, dates of visits prior to the initiation of anti-tuberculosis treatment, and direct OOP medical costs associated with TB diagnosis. Logistic regression analysis examined the factors associated with delays in treatment initiation and OOP expenditures.Of 880 TB patients interviewed, 34.7% presented to public health facilities and 65% patients sought private health facilities as their first point of care. The average monthly individual income was $77.79 (SD 57.14). About 69% incurred some pre-treatment costs at an average of $39.74. Overall, patients experienced a median of 6 days (3-11 IQR) of time to treatment initiation and 21 days (10-30 IQR) of health systems delay. Age ≤ 40 years (aOR: 1.73; CI: 1.22-2.44), diabetes (aOR: 1.63; CI: 1.08-2.44) and first visit to a private health facility (aOR: 17.2; CI: 11.1-26.4) were associated with higher direct OOP medical costs, while age ≤ 40 years (aOR: 0.64; CI: 0.48-0.85) and first visit to private health facility (aOR: 1.79, CI: 1.34-2.39) were associated with health systems delay.The majority of rural TB patients registering at PHCs visited private health facilities first and incurred substantial direct OOP medical costs and delays prior to diagnosis and anti-tuberculosis treatment initiation. This study highlights the need for PHCs to be made as the preferred choice for first point of contact, to combat TB more efficiently.http://europepmc.org/articles/PMC5802859?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Karun Sandeep Veesa
Kamalabhai Russell John
Patrick K Moonan
Saravanakumar Puthupalayam Kaliappan
Krishna Manjunath
Karuna D Sagili
Chinnappareddy Ravichandra
Pradeep Aravindan Menon
Chandrakumar Dolla
Nancy Luke
Kaivan Munshi
Kuryan George
Shantidani Minz
spellingShingle Karun Sandeep Veesa
Kamalabhai Russell John
Patrick K Moonan
Saravanakumar Puthupalayam Kaliappan
Krishna Manjunath
Karuna D Sagili
Chinnappareddy Ravichandra
Pradeep Aravindan Menon
Chandrakumar Dolla
Nancy Luke
Kaivan Munshi
Kuryan George
Shantidani Minz
Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
PLoS ONE
author_facet Karun Sandeep Veesa
Kamalabhai Russell John
Patrick K Moonan
Saravanakumar Puthupalayam Kaliappan
Krishna Manjunath
Karuna D Sagili
Chinnappareddy Ravichandra
Pradeep Aravindan Menon
Chandrakumar Dolla
Nancy Luke
Kaivan Munshi
Kuryan George
Shantidani Minz
author_sort Karun Sandeep Veesa
title Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
title_short Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
title_full Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
title_fullStr Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
title_full_unstemmed Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
title_sort diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - tamil nadu, india.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description Tuberculosis (TB) patients face substantial delays prior to treatment initiation, and out of pocket (OOP) expenditures often surpass the economic productivity of the household. We evaluated the pre-diagnostic cost and health seeking behaviour of new adult pulmonary TB patients registered at Primary Health Centres (PHCs) in Vellore district, Tamil Nadu, India.This descriptive study, part of a randomised controlled trial conducted in three rural Tuberculosis Units from Dec 2012 to Dec 2015, collected data on number of health facilities, dates of visits prior to the initiation of anti-tuberculosis treatment, and direct OOP medical costs associated with TB diagnosis. Logistic regression analysis examined the factors associated with delays in treatment initiation and OOP expenditures.Of 880 TB patients interviewed, 34.7% presented to public health facilities and 65% patients sought private health facilities as their first point of care. The average monthly individual income was $77.79 (SD 57.14). About 69% incurred some pre-treatment costs at an average of $39.74. Overall, patients experienced a median of 6 days (3-11 IQR) of time to treatment initiation and 21 days (10-30 IQR) of health systems delay. Age ≤ 40 years (aOR: 1.73; CI: 1.22-2.44), diabetes (aOR: 1.63; CI: 1.08-2.44) and first visit to a private health facility (aOR: 17.2; CI: 11.1-26.4) were associated with higher direct OOP medical costs, while age ≤ 40 years (aOR: 0.64; CI: 0.48-0.85) and first visit to private health facility (aOR: 1.79, CI: 1.34-2.39) were associated with health systems delay.The majority of rural TB patients registering at PHCs visited private health facilities first and incurred substantial direct OOP medical costs and delays prior to diagnosis and anti-tuberculosis treatment initiation. This study highlights the need for PHCs to be made as the preferred choice for first point of contact, to combat TB more efficiently.
url http://europepmc.org/articles/PMC5802859?pdf=render
work_keys_str_mv AT karunsandeepveesa diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT kamalabhairusselljohn diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT patrickkmoonan diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT saravanakumarputhupalayamkaliappan diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT krishnamanjunath diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT karunadsagili diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT chinnappareddyravichandra diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT pradeeparavindanmenon diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT chandrakumardolla diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT nancyluke diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT kaivanmunshi diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT kuryangeorge diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
AT shantidaniminz diagnosticpathwaysanddirectmedicalcostsincurredbynewadultpulmonarytuberculosispatientspriortoantituberculosistreatmenttamilnaduindia
_version_ 1725244643079094272